Chloe Molimard - Publications

Corrigendum to "Combination of CDX2H-score quantitative analysis with CD3 AI-guided analysis identifies patients with a good prognosis only in stage III colon cancer" [In European Journal of Cancer, Volume 172, 2022, Pages 221-230, ISSN 0959-8049].

Journal: European journal of cancer (Oxford, England : 1990)

Published: April 07, 2026

Dynamic DNA methylation changes during colorectal oncogenesis with insights from adenoma stages.

Journal: Scientific reports

Published: June 20, 2025

Organizing pneumonia in patients on dupilumab therapy for nasal polyposis: A report of three cases.

Journal: The journal of allergy and clinical immunology. In practice

Published: February 26, 2025

Characterization and clinical outcomes of rare biliary adenosquamous carcinoma.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: January 13, 2025

Human Papillomavirus Infection Is a Favorable Prognostic Factor for Patients With Stages I to IVA Esophageal Squamous Cell Carcinoma but not Adenocarcinoma.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Published: December 11, 2024

Deep Multiple Instance Learning Model to Predict Outcome of Pancreatic Cancer Following Surgery.

Journal: Biomedicines

Published: September 30, 2024

COL25A1 and METAP1D DNA methylation are promising liquid biopsy epigenetic biomarkers of colorectal cancer using digital PCR.

Journal: Clinical epigenetics

Published: July 08, 2024

Paving the way to a new tumor regression grade in digestive oncology.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: June 09, 2024

Temporal and spatial heterogeneity of HER2 status in metastatic colorectal cancer.

Journal: Diagnostic pathology

Published: April 10, 2024

Prognostic Factors for Long-Term Eribulin Response in a Cohort of Patients With HER2-Negative Metastatic Breast Cancer.

Journal: Clinical breast cancer

Published: March 09, 2024

Evaluation of immune infiltrate according to the HER2 status in colorectal cancer.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: April 01, 2023

SALL4-related gene signature defines a specific stromal subset of pancreatic ductal adenocarcinoma with poor prognostic features.

Journal: Molecular oncology

Published: August 18, 2022